Meet Hepatologist Dr. Augusto Villanueva Rodriguez

NYU Langone Health
NYU Langone HealthMar 31, 2026

Why It Matters

By centering care on the individual and leveraging a collaborative, evidence‑driven framework, Dr. Villanueva’s approach improves patient outcomes and establishes a replicable standard for complex cancer treatment programs.

Key Takeaways

  • Patient care prioritizes individual needs over disease labels.
  • Multidisciplinary collaboration essential for liver cancer treatment team.
  • Evidence‑based yet innovative approaches guide therapy choices for patients.
  • Clear communication ensures patients understand next steps in treatment.
  • Program commits to comprehensive support throughout cancer journey.

Summary

The video introduces Dr. Augusto Villanueva Rodriguez, medical director of NYU Langone Health’s liver tumor program, and outlines his personal journey into hepatology. Raised in a family of physicians, he blends a lifelong fascination with biology and a commitment to patient service, positioning himself at the intersection of science and compassionate care.

Dr. Villanueva articulates three guiding principles: treating the patient as a whole person rather than a collection of symptoms, fostering multidisciplinary collaboration to balance aggressive cancer eradication with preservation of liver function, and grounding treatment decisions in evidence‑based medicine while staying open to innovative therapies. He stresses that liver cancer often co‑exists with cirrhosis, making a coordinated approach among surgeons, oncologists, radiologists, and transplant specialists indispensable.

Key quotations underscore his philosophy: “I treat patients, not diseases,” and “We’re here to support you every step of the way.” He emphasizes clear, step‑by‑step communication so patients leave each visit with a concrete understanding of their care plan, even when answers are still evolving.

The implications are twofold: patients receive a more personalized, transparent experience that can improve adherence and outcomes, and the program sets a benchmark for other institutions seeking to integrate patient‑centered care with cutting‑edge liver oncology. This model may drive broader adoption of multidisciplinary tumor boards and continuous education on emerging therapies across the healthcare system.

Original Description

Augusto Villanueva Rodriguez, MD, PhD is a hepatologist and Medical Director of the Liver Tumor Program at NYU Langone Health. He specializes in caring for people with liver cancer and complex liver diseases, including cirrhosis, viral hepatitis, fatty liver disease, and autoimmune liver disorders.
Dr. Villanueva comes from a family of physicians and was inspired early in life by the impact doctors can have on patients and families. He is drawn to medicine because it combines helping people with solving complex biological problems. His philosophy of care is centered on treating the whole person, not just the disease. He takes time to understand each patient’s needs, concerns, and goals, and believes that clear communication and partnership are essential throughout the cancer journey.
Expertise
Dr. Villanueva treats a wide range of liver conditions, including:
• Primary liver cancer, including hepatocellular carcinoma
• Liver tumors related to cirrhosis or chronic hepatitis
• Cirrhosis and its complications
• Viral hepatitis
• Fatty liver disease
• Autoimmune liver diseases
Dr. Villanueva develops individualized treatment plans based on each patient’s overall health and liver function. Care may include advanced medical therapies, close monitoring, and procedures that target tumors while preserving as much healthy liver tissue as possible. When surgery or other invasive treatments are considered, decisions are made carefully to balance cancer control with safety and quality of life.
He works closely with a multidisciplinary team that includes hepatologists, medical oncologists, interventional radiologists, surgeons, pathologists, and transplant specialists. This collaboration is central to the Liver Tumor Program at NYU Langone and helps ensure that patients receive coordinated, comprehensive care that reflects the latest evidence and treatment options.

Comments

Want to join the conversation?

Loading comments...